Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Vinblastine Study for Standard-Risk ALK-positive ALCL in Children and Adolescents
DRKS00023541Phase 3Recruiting
- Sponsor
- German Society for Pediatric Oncology and Hematology
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 3, open-label, single-arm trial of vinblastine in anaplastic large cell lymphoma (ALCL), sponsored by German Society for Pediatric Oncology and Hematology. Started Mar 2021; status: recruiting.
02
Drugs
vinblastine
03
Conditions
anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on DRKS00023541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00023541.